US2004077003A1PendingUtilityA1
Composition for the detection of blood cell and immunological response gene expression
Est. expiryFeb 9, 2018(expired)· nominal 20-yr term from priority
C12Q 1/6883C12Q 2600/158
61
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention relates to a composition comprising a plurality of polynucleotide probes. The composition can be used as hybridizable array elements in a microarray. The present invention also relates to a method for selecting polynucleotide probes for the composition.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . A composition comprising a plurality of polynucleotide probes, wherein said plurality of polynucleotide probes comprise:
I) first polynucleotide probes, wherein each of said first polynucleotide probes comprises at least a portion of a gene differentially expressed in an immunological response; II) second polynucleotide probes, wherein each of said second polynucleotide probes comprises at least a portion of a gene abundantly expressed in an immunological response; and III) third polynucleotide probes, wherein each of said third polynucleotide probes comprises at least a portion of a gene coding for a polypeptide known to regulate blood cell biology.
2 . The composition of claim 1 , wherein each of said first polynucleotide probes is selected by a first method comprising:
a) preparing at least one first target transcript profile from a first biological sample selected from the group consisting of hematopoietic cells and inflamed tissue and at least one first subtraction transcript profile from a noninflamed, nonhematopoietic biological sample; b) subtracting said first subtraction transcript profile from said first target profile to detect a plurality of genes that are differentially expressed in an immunological response; and c) identifying one of said detected genes that are differentially expressed in an immunological response.
3 . The composition of claim 1 , wherein each of said second polynucleotide probes is selected by a second method comprising:
a) preparing at least one second target transcript profile from a second biological sample selected from the group consisting of hematopoietic cells and inflamed tissue to detect genes that are abundantly expressed in said second biological sample; and b) identifying one of said detected genes that are abundantly expressed.
4 . The composition of claim 1 , wherein each of said third polynucleotide probes is selected by a third method comprising identifying a gene coding for a polypeptide with a known function in immunological responses.
5 . An isolated polynucleotide selected from the group consisting of SEQ ID NOs:1-1508, or the complete complement thereof.
6 . The polynucleotide of claim 5 , wherein said polynucleotide is immobilized on a substrate.
7 . The polynucleotide of claim 5 , wherein said polynucleotide is a hybridizable element on a microarray.
8 . A composition comprising the polynucleotide of claim 5 and a labeling moiety.
9 . A method for using a polynucleotide to detect expression of a nucleic acid in a sample comprising:
a) hybridizing the composition of claim 8 to nucleic acids of the sample under conditions to form at least one hybridization complex; and b) detecting hybridization complex formation, wherein complex formation indicates expression of the nucleic acid in the sample.
10 . The method of claim 9 further comprising amplifying the nucleic acids of the sample prior to hybridization.
11 . The method of claim 10 wherein complex formation is compared to a standard and is diagnostic of an immunopathological condition.Join the waitlist — get patent alerts
Track US2004077003A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.